AI in Lab Automation Market Trends and Top Principal Companies

The AI in lab automation market is driven by the expanding healthcare applications and growing innovations, report Towards Healthcare a sister firm of Precedence Research.

Ottawa, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The global AI in Lab Automation market is rapidly emerging as a high-growth sector, expected to experience significant revenue growth between 2024 and 2034. This surge is fueled by swift technological advancements and evolving industry needs, as laboratories increasingly implement AI-powered solutions to boost efficiency, accuracy, and productivity in both research and diagnostic processes.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5743

Key Takeaways

North America dominated the market in 2024.
Asia-Pacific is expected to witness the fastest growth in the AI in lab automation market during the forecast period.
By process, the continuous flow segment dominated the market in 2024.
By process, the discrete processing segment is expected to be the fastest growing during the forecast period.
By application, the drug discovery segment dominated the market in 2024.
By application, the clinical diagnostics segment is expected to be the fastest growing during the forecast period.
By automation, the modular automation system segment dominated the market in 2024.
By automation, the total lab automation segment is expected to be the fastest growing during the forecast period.
By end-user, the pharmaceutical and biotechnology companies segment dominated the market in 2024.
By end user, the contract research organization segment is expected to be the fastest growing during the forecast period.

Market Overview & Potential

The AI in lab automation market is driven by growing demand for enhanced data analysis, drug discovery acceleration, cloud-based solutions, intelligent robotics, and many more. The AI in lab automation refers to the advanced technologies like machine learning and intelligent algorithms, etc, used to automate, improve, and optimize laboratory processes. They can be used for drug discovery & development, clinical diagnostics, quality control, genomics, personalized medicine, etc.

What are the Major Growth Drivers of AI in the Lab Automation Market?

The growing demand for high throughput is the major driver increasing the adoption of AI in lab automation. They help in conducting repetitive and time-consuming tasks with minimized errors and achieve optimization. The increasing experimental complexities, demand for regulatory compliance, and growing technological innovation are other market drivers.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What are the Key Drifts in the AI in Lab Automation Market?

The market has been expanding due to the growing funding, collaborations, and investments to launch and enhance AI in lab automation solutions.

In September 2025, a total of USD 7.2 million was secured in the Series A funding by the AI healthcare startup Reveal HealthTech. This funding will be used to scale BioCanvas, a multimodal artificial intelligence enhancing clinical trial recruitment and oncology research, and Prism AI, which helps in streamlining the healthcare operations workflow automation.
In September 2025, a collaboration between LYL and Hai Robotics was announced, where they will focus on providing modular, scalable warehouse automation solutions customized to the needs of the Spanish market.
In May 2025, an investment from Khosla Ventures, which is a leading backer of transformative AI companies, was announced by R1 after the successful launch of R37, developed in collaboration between R1 and Palantir.
In January 2025, a total of $42 million was secured by the Automata, which is a pioneering company in the realm of lab automation, in its latest funding round.

What is the Significant Challenge in the AI in Lab Automation Market?

High cost act as the major limitation as the AI in lab automation require high initial investments. It also requires IT infrastructure, which limits its use by various small labs. Additionally, the lack of trained personnel, complex integration, privacy concerns, and regulatory hurdles are other challenges in the market.

Regional Analysis

Why did North America Dominate the AI in Lab Automation Market in 2024?

North America captured the biggest revenue share of the market in 2024, due to the presence of various healthcare industries. The healthcare investments also supported their adoption. This increased their use, application, as well as innovations. Moreover, they were also used for personal treatment development, where all these advancements contributed to the market growth.

What Made the Asia Pacific Grow Notably in the AI in Lab Automation Market in 2024?

The Asia Pacific is estimated to be the fastest-growing region in the market during the upcoming years, driven by the expanding industries and growth support, which increases their utilization. The growing demand for diagnostics is also increasing their use. The affordable and scalable solution with robotic or cloud-based applications is also being developed, which is enhancing the market growth.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

Segmental Insights

By process analysis

Why Did the Continuous Flow Segment Dominate in the AI in Lab Automation Market in 2024?

By process, the continuous flow segment held the largest share of the market in 2024, as it provided high throughput with fast results. It was also used for analyzing and optimizing the data. Moreover, it also helped in minimizing the errors, providing enhanced accuracy and consistency, as well as it as helped in accelerating the R&D.

By process, the discrete processing segment is expected to show the fastest growth rate during the upcoming years. They can be used in the development of diverse sample types along with the development of personalized medications. At the same time, their demand for diagnostic purposes is increasing for biological assays.

By application analysis

What Made Drug Discovery the Dominant Segment in the AI in Lab Automation Market in 2024?

By application, the drug discovery segment led the market in 2024, as the AI in lab automation helped in the analysis of a vast amount of data. It also provided high-throughput screening, accelerating the R&D. It also helped in identifying the targets, predicting the drug candidate efficacy, etc., which increased their use.

By application, the clinical diagnostics segment is expected to show the highest growth during the upcoming years. The growing incidence of disease is increasing the use of AI in lab automation for its diagnosis. They provide fast, accurate results as well as promote remote patient monitoring.

By automation analysis

Which Automation Type Segment Held the Dominating Share of the AI in Lab Automation Market in 2024?

By automation, the modular automation system segment held the dominating share of the market in 2024, due to its flexibility depending on the experiment and workflow. They provided fast installation and low upfront cost. Additionally, they were used for liquid sample handling, data analysis, and imaging.

By automation, the total lab automation segment is expected to show the fastest growth rate during the predicted time. The entire workflow is automated with their use. This, in turn, helps in reducing manual labor, errors, and limitations, along with continuous monitoring and optimization of the process.

By end-user analysis

How the Pharmaceutical and Biotechnology Companies Segment Dominated the AI in Lab Automation Market in 2024?

By end-user, the pharmaceutical and biotechnology companies segment led the market in 2024, driven by growth in R&D and their investments. This increased the adoption of AI in lad automation to accelerate the R&D. They helped in overcoming the challenges and enhanced the development process.

By end user, the contract research organization segment is expected to show the highest growth during the predicted time. Due to the growing outsourcing trend, their demand is increasing. The documentation and traceability are also enhanced during the regulatory submission, and accelerate the clinical trials.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

Recent Developments in the AI in Lab Automation Market

In September 2025, to launch the TCS Innovation Lab in Bengaluru for developing scalable and smart Edge AI solutions, a collaboration between Tata Consultancy Services (TCS) and Qualcomm was announced.
In September 2025, an AI agent was developed by Allot to identify and address health inequalities utilizing the agentic integration platform of SnapLogic to optimize resource allocation and enhance patient outcomes.
In January 2025, Automated Industrial Robotics Inc., which is a recently developed industrial automation company to capitalize on the growing manufacturing automation solutions global demand, was launched by Ares Management Corporation.

AI in Lab Automation Market Key Players List

Danaher
Thermo Fisher Scientific
PerkinElmer
Agilent Technologies
Siemens Healthineers
Eppendorf SE
Tecan
Becton Dickinson
Hudason Robotics, Inc

Browse More Insights of Towards Healthcare:

The global pharmacy automation devices market is valued at US$ 7.6 billion in 2024, expected to reach US$ 8.37 billion in 2025, and projected to expand to approximately US$ 19.9 billion by 2034, growing at a CAGR of 10.1% between 2025 and 2034.
The digital health automation market is on a strong growth trajectory, anticipated to generate substantial revenues and potentially scale into the hundreds of millions over the forecast period from 2025 to 2034.
The life science lab equipment market stands at USD 57.71 billion in 2024, increasing to USD 61.08 billion in 2025, and is forecasted to reach about USD 101.37 billion by 2034, expanding at a CAGR of 5.84% between 2025 and 2034.
The medtech labeling automation market is witnessing robust growth, with revenues projected to climb into the hundreds of millions by the end of the forecast window (2025–2034).
The pharmacovigilance automation market is rapidly advancing worldwide, with expectations of generating hundreds of millions in revenue across the forecast years from 2025 to 2034.
The bioprocess automation market is valued at USD 5.4 billion in 2024, estimated to grow to USD 6.05 billion in 2025, and projected to reach approximately USD 16.88 billion by 2034, progressing at a CAGR of 12.04% during 2025–2034.
The lab automation market is valued at USD 7.87 billion in 2024, expanding to USD 8.39 billion in 2025, and anticipated to reach nearly USD 15 billion by 2034, at a CAGR of 6.67% over the forecast period.
The total lab automation market is valued at US$ 5.68 billion in 2024, increasing to US$ 6.09 billion in 2025, and is projected to hit around US$ 11.3 billion by 2034, expanding at a CAGR of 7.15% from 2025 to 2034.
The pharmacy automation market is estimated at USD 6.35 billion in 2024, rising to USD 6.99 billion in 2025, and projected to reach USD 16.65 billion by 2034, recording a CAGR of 10.12% during the forecast years.
The healthcare automation market is expected to grow from USD 42.91 billion in 2025 to approximately USD 95.53 billion by 2034, advancing at a CAGR of 9.3% throughout the forecast period.

Segments Covered in The Report

By Process Type

Continuous Flow
Discrete Processing

By Application

Drug Discovery
Clinical Diagnostics
Genomics and Proteomics
Microbiology
Other Research Applications

By Automation Type

Modular Automation Systems
Total Lab Automation (TLA)

By End-User

Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Contract Research Organizations (CROs)
Hospitals and Diagnostic Labs

By Region

North America

U.S.
Canada

Asia Pacific

China
Japan
India
South Korea
Thailand

Europe

Germany
UK
France
Italy
Spain
Sweden
Denmark
Norway

Latin America

Brazil Mexico
Argentina

Middle East and Africa (MEA)

South Africa
UAE
Saudi Arabia
Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5743

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.